SLPMeta-AnalysisAmerican journal of physical medicine & rehabilitation2020

Effects of Transcutaneous Neuromuscular Electrical Stimulation on Swallowing Disorders: A Systematic Review and Meta-Analysis.

Yuanyuan Sun, Xiaoyun Chen, Jianhong Qiao and 7 others

PMID 32209833

WHAT IT FOUND

Transcutaneous NMES combined with standard therapy improved swallowing in adults with brain injury, but showed no benefit for head and neck cancer or Parkinson disease.

The overall evidence quality is low, so this should not replace standard care without further testing.

Key findings

01NMES plus standard therapy significantly improved swallowing function overall compared to controls.

02Benefit was seen in acquired brain injury groups, but not in head and neck cancer or Parkinson disease groups.

03Evidence quality was rated as low to very low due to bias and inconsistency.

STILL TO COME

How it was doneWhat they foundWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The quality of evidence was low to very low due to high risk of bias in included studies, particularly lack of blinding and allocation concealment. There was significant heterogeneity across studies regarding patient characteristics, stimulation parameters, and outcome measures. Most studies measured short-term outcomes immediately after intervention; long-term effectiveness remains unclear. The review included only English-language studies, which may introduce publication bias. Sample sizes in individual studies were small, leading to imprecision in estimates.

Declared interests

No specific funding sources or conflicts of interest were detailed in the provided text, though the paper was published in a rehabilitation journal.

The easy way to misread this

Do not assume NMES is effective for all dysphagia etiologies. The benefit was driven by the brain injury subgroup; the analysis showed no significant improvement for head and neck cancer or Parkinson disease patients. Additionally, the overall evidence quality is low, meaning the observed effects may not be reliable.

Read it on PubMed →